2 1 M A Y 2 0 1 5 | V O L 5 2 1 | N A T U R E | 3 5 5 LETTER RESEARCH G2015 Macmillan Publishers Limited. All rights reserved later time points during human reprogramming 11,25 , and we speculate a similar transient intermediate arises in the human system.
In the context of most induced pluripotent stem (iPS) cell reprogramming methods, heterogeneous populations of non-productive and staggered productive intermediates arise at different reprogramming time points [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Despite recent reports claiming substantially increased reprogramming efficiencies using genetically modified donor cells 12, 13 , prospectively isolating distinct reprogramming intermediates remains an important goal to decipher reprogramming mechanisms. Previous attempts to identify surface markers of intermediate cell populations were based on the assumption that, during reprogramming, cells progressively lose donor cell identity and gradually acquire iPS cell properties 1, 2, 7, 8, 10 . Here we report that iPS cell and epithelial markers, such as SSEA1 and EpCAM, respectively, are not predictive of reprogramming during early phases. Instead, in a systematic functional surface marker screen, we find that early reprogramming-prone cells express a unique set of surface markers, including CD73, CD49d and CD200, that are absent in both fibroblasts and iPS cells. Single-cell mass cytometry and prospective isolation show that these distinct intermediates are transient and bridge the gap between donor cell silencing and pluripotency marker acquisition during the early, presumably stochastic, reprogramming phase 2 . Expression profiling reveals early upregulation of the transcriptional regulators Nr0b1 and Etv5 in this reprogramming state, preceding activation of key pluripotency regulators such as Rex1 (also known as Zfp42), Dppa2, Nanog and Sox2. Both factors are required for the generation of the early intermediate state and fully reprogrammed iPS cells, and thus represent some of the earliest known regulators of iPS cell induction. Our study deconvolutes the first steps in a hierarchical series of events that lead to pluripotency acquisition.
Reprogramming somatic cells to a pluripotent state by forced transcription factor expression is typically an inefficient process involving heterogeneous populations that impede molecular analysis of productive reprogramming [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] 14 . Previous studies have shown that reprogramming is a multi-stage process involving presumably early stochastic and late deterministic phases 2, 3, 5 . Progress has been made characterizing intermediates of the late phase given the appearance of well-known pluripotency markers at that time 1, 2, 7, 8, 10, 15 . In contrast, not much is known about the early stochastic phase except the consistent observation that downregulation of donor cell markers is an early feature of successful reprogramming 1, 2, 7, 8, 10, [15] [16] [17] [18] [19] [20] .
To identify surface markers of early reprogramming stages, we screened 176 antibodies on cells representing three stages of the reprogramming process: (1) mouse embryonic fibroblasts (MEFs), (2) a previously characterized partially reprogrammed cell (PRC) line 18, 20, 21 and (3) embryonic stem cells (ESCs). We identified 21 markers enriched or shared between these cell types and characterized their co-expression by singlecell mass cytometry using spanning-tree progression analysis of densitynormalized events (SPADE), which groups similar cells into a defined number of clusters 22, 23 (Fig. 1a, b and Extended Data Fig. 1 ). Next, we characterized their expression by mass cytometry during Oct4-, Sox2-, Klf4-and c-Myc-driven MEF reprogramming. By day 3, downregulation of the fibroblast expression program was evident ( Fig. 1c and Extended Data Figs 2 and 3) . At day 6, major branches were delineated by the PRC marker CD73 and ESC markers CD54, CD326 and SSEA1. Little co-expression was observed between these markers, suggesting several intermediates arise during early reprogramming or early expression of some of these markers may not be indicative of productive reprogramming. By day 9, CD326 and SSEA1 expression converged in a subpopulation and persisted on days 12 and 16 (Extended Data Fig. 2b ). These clusters were heterogeneous for CD73, suggesting they may be derivatives of separate populations or a CD73 high subpopulation becomes CD326 high , SSEA1 high . Over our time course, the ESC marker CD54 largely localized to fibroblast branches and did not cluster with CD326 high and SSEA1 high clusters, suggesting CD54 expression in pluripotent cells is a late event 7 .
Hypothesizing that cells destined to successfully reprogram acquire surface markers in a stepwise, non-stochastic manner during early reprogramming, we assessed reprogramming efficiencies for cells with high or low expression of the above-characterized surface markers at early time points ( Fig. 2a -c and Extended Data Fig. 4a ). As mass culture experiments can be misleading because a single proliferative population can seed multiple secondary colonies, we conducted 96-well assays to assess unique reprogramming events. On the basis of the current literature it would be expected that reprogramming cells would be enriched by (1) low levels of fibroblast markers and (2) high levels of ESC markers independent of the time and state of reprogramming 2, 7, 8, 10 . Indeed, by day 3, populations expressing low levels of all fibroblast markers except CD47 enriched for reprogramming populations compared with highly expressing populations ( Fig. 2a ). Surprisingly though, at these early time points, cells with high levels of the ESC markers SSEA1, CD54, CD326 or CD71 did not show significantly increased reprogramming ( Fig. 2a -c). Day 9 fractions expressing high levels of CD326 or SSEA1 began to show greater but insignificant enrichment for reprogramming populations. We confirmed previous reports that SSEA1-sorted cells produce more iPS cell colonies in mass culture 1, 8, 10 , emphasizing the critical importance of the 96-well assay (Extended Data Fig. 4b, c ). Unlike what was previously assumed, our findings demonstrate that acquisition of markers that define the pluripotent state is a late event and early expression of ESC markers has little predictive value for successful reprogramming. Additionally these data support the idea that the mesenchymal-to-epithelial transition, as judged by the epithelial marker CD326 (EpCAM), is a late event 2, [15] [16] [17] [18] 20 .
Our surface marker screen identified several specific markers for stable, partially reprogrammed cells 4, 9, 18, 21 (Fig. 1a ). Although thought to be 'stuck' during reprogramming 4, 18, 21 , we hypothesized a productive intermediate might arise between fibroblasts and iPS cells that share a subset of these markers. Indeed, day 6 fractions expressing high levels of the PRC markers CD73, CD49d and CD200 significantly enriched for reprogramming populations (Fig. 2b) . Also, on day 9 the CD73 high and CD49d high populations contained higher reprogramming activity ( Fig. 2c ). In agreement with these results, the day 6 SPADE analysis showed CD73 high , CD49d high and CD200 high branches largely clustering independently from branches enriched for ESC and MEF markers ( Fig. 1c ). These results demonstrate that distinct intermediate populations arise after fibroblast program repression but before ESC marker acquisition.
We next focused on the markers CD73 and CD49d. When corrected for plating efficiency, both CD73 high and CD49d high populations showed remarkably high reprogramming efficiencies of 9.5% 6 3.5 and 12.5% 6 5.7, respectively ( Fig. 2d-f ). Similar enrichment of a reprogrammingprone population was observed in reprogramming tail tip fibroblasts and glial-restricted neural precursor cells, suggesting CD73 and CD49d may be universal markers of intermediate reprogramming stages (Fig. 3a-d ).
Finally, we explored their potential functional implications during reprogramming, and observed that adenosine, the enzymatic product of CD73, has a negative effect throughout and that CD49d activity is necessary during late reprogramming (Extended Data Fig. 4e ).
We then used our day 6 SPADE analysis to identify heterogeneously expressed markers that could subdivide the CD73 high reprogrammingprone population and conducted single-cell efficiency assays ( Fig. 3e, f LETTER RESEARCH ( Fig. 3g ). As expected, MEF markers were low in these poised populations. This suggests that this intermediate arises after loss of mesenchymal markers, but before completion of mesenchymal-to-epithelial transition, as indicated by reprogramming enrichment in the CD326 low fraction.
To identify subsequent reprogramming stages, we conducted continuation analysis where cells were sorted on day 6 and characterized by mass cytometry on day 16 ( Fig. 3h and Extended Data Fig. 4-6 ). By day 10, reprogramming-prone populations formed distinct colonies with ESC-like morphology, while CD73 low cells were highly proliferative but failed to develop into mature colonies (Extended Data Fig. 5b ). Continuation analysis on day 16 revealed that while reprogrammingprone and non-prone populations contained CD326-expressing cells, broad overlap between CD326 high and SSEA1 high clusters was only in mature reprogramming-prone populations ( Fig. 3h and Extended Data Fig. 6 ). These clusters did not overlap with the ESC marker CD54, and were heterogeneous for CD73 and CD49d. We conclude a distinct CD326 high , SSEA1 high , CD54 low intermediate arises after the CD73 high / CD49d high intermediate and before pluripotency acquisition.
We then used the intermediates stages to gain molecular insights into transcriptional regulation of early reprogramming. Gene expression analysis intriguingly showed these intermediates precede activation of the majority of transcription factors thought to be predictive markers for pluripotency induction ( Fig. 4a and Extended Data Fig. 7 ) 2,7 . The observation that these intermediates arise before key pluripotency regulators suggests a separate combination of early transcription factors must be induced to generate early intermediates and poise them for pluripotency acquisition. We found the transcription factors Nr0b1 and Etv5 preferentially expressed in reprogramming-prone populations and highly expressed in ESCs, suggesting a functional role in poising early reprogramming ( Fig. 4a and Extended Data Fig. 7b-d ).
To assess whether these genes were necessary to induce the early intermediate populations, we generated three short hairpins against each gene (Extended Data Fig. 7e , f). We then assessed the ability of reprogramming MEFs infected with these short hairpins to induce CD73 high / CD49d high intermediates 9 days after reprogramming induction ( Fig. 4b and Extended Data Fig. 7g) . Surprisingly, while MEFs infected with a control short hairpin were able to induce the CD73 high /CD49 high intermediate (6.70 6 2.27%), reprogramming MEFs infected with short hairpins targeting Etv5 or Nr0b1 were significantly impaired ( Fig. 4b ). This phenotype could be rescued by complementary DNA (cDNA) overexpression in combination with a hairpin targeting the untranslated region for the gene of interest ( Fig. 4c ). Further, when Nanog 1 colonies or Sox2-eGFP 1 colonies were assessed 24 days after reprogramming induction, a dramatic decrease in reprogramming efficiencies was observed ( Fig. 4d, e ). In contrast, knockdown of either gene in ESCs did not affect survival or proliferation (Extended Data Fig. 7h ). While this paper was under review, an independent report confirmed Nr0b1 as necessary for reprogramming 24 . These data indicate that Etv5 and Nr0b1 are required to generate the CD73 high /CD49d high poised intermediate necessary to induce the canonical pluripotency program and definitive iPS cell formation.
We then wondered whether a similar intermediate population arises in high-efficiency reprogramming systems 12, 13 . Published expression analysis of two high-efficiency systems showed transient CD73 upregulation, suggesting the presence of a similar intermediate (Extended Data Fig. 8a, b ). We then characterized one of these systems, the Mbd3 fl/2 secondary MEF system, in greater detail 12 . After confirming reported Fig. 4f ).
The stage-specific framework provided in this study bridges the previously unexplored gap between donor program silencing and pluripotent marker acquisition (Fig. 4f Alpl Etv5  Sall4  Fbxo15  Tcf3  Stat3  Tfcp2l1  Klf5  Dppa2  Dppa4  Esrrb  Lin28a  Nanog  Rex1  Sox2  Tbx3  Mbd3  Klf2  Zfp296  Utf1   D6: CD73 
METHODS
No statistical methods were used to predetermine sample size. Cell culture. Embryonic fibroblasts were isolated from embryonic day (E)13.5 embryos derived from B6;129S-Sox2 eGFP/1 mated with B6.Cg-Gt(ROSA)26Sor tm1(rtTA * M2)Jae (allele referred to as Rosa-rtTA) as previously described 26, 27 . Tail tip fibroblasts were derived from 1-week-old B6 mice. This was done by chilling the animals on ice for 5 min, cutting the tail, and mincing in a 6 cm dish in 1 ml 0.25% trypsin. Another 1 ml of 0.25% trypsin was added after mincing and this was incubated at 37 uC for 10 min. The mixture was then resuspended in 15 ml MEF medium (described below) and plated on a 0.2% gelatinized 15 cm plate. Glial cultures were prepared from CD1 mice as previously described 26 . MEFs, tail tip fibroblasts and glial cells were cultured in MEF medium, which consisted of 10% cosmic calf serum (Thermo Scientific) in DMEM (Invitrogen) supplemented with non-essential amino acids (Invitrogen), penicillin-streptomycin (Invitrogen), sodium pyruvate (Invitrogen) and 2-mercaptoethanol (Invitrogen). Primary Mbd3 fl/2 , Oct4-GFP secondary MEFs 12 were a gift from J. Hanna and grown in MEF medium. We verified modification of the Mbd3 locus by western blot analysis (described below under 'Western blotting'; Extended Data Fig. 8f ). Our partially reprogrammed line was previously characterized 15, 21 . These were grown in MEF medium supplemented with 15% cosmic calf serum. Oct4-neoR knock-in mouse ESCs 19, 21 were grown in mESC medium, which consisted of 12% knockout replacement serum (Invitrogen), 3% cosmic calf serum and supplemented with non-essential amino acids, penicillin-streptomycin, sodium pyruvate, 2-mercaptoethanol and leukaemia inhibitory factor (LIF). MEFs, PRCs and mESCs were routinely tested for mycoplasma contamination. Surface marker screening. We screened mouse surface markers using the 'Mouse cell surface marker screening panel' Lyoplate (BD Biosciences, material number 562208) according to the manufacturer's instructions. Briefly, 150 3 10 6 cells were used for our partially reprogrammed cells (passage 15) and Oct4-neoR mES cells. Cells were plated on 0.2% gelatin-coated plates and treated with neomycin 3 days before screening; 175 3 10 6 cells were used for passage 4 Sox2-eGFP MEFs. Cells were washed with PBS-EDTA, dissociated in 103 TrypLE (Invitrogen) for 5 min, washed once in PBS before staining for 30 min in primary antibody in staining medium (PBS-EDTA supplemented with 0.5% BSA) according to manufacturer's instructions. After the primary antibody stain, cells were washed two times in PBS, stained for 30 min. on ice with biotinylated secondary antibodies in staining medium, washed two times in PBS, and then stained for 30 min. on ice with Alexafluor 647-conjugated streptavidin in staining medium. After the tertiary Alexafluor 647-streptavidin stain, the cells were washed twice in PBS and analysed on a BD LSR II Flow Cytometer with 96-well HTS module in staining medium. We used a high concentration of TrypLE to verify that all identified markers would not be cleaved by our dissociation reagent. We further validated a subset of these identified makers with our control populations dissociated in 13 TrypLE and stained with fluorophore-conjugated antibodies as described below.
Reprogramming. Reprogramming assays were conducted with passage 4 Rosa-rtTA 6 ; Sox2 eGFP/1 or Rosa-rtTA 6 (derived from the same litter: see mating scheme above) mouse embryonic fibroblasts, passage 2 B6 tail tip fibroblasts or passage 3 B6 glia as indicated. FUW-tetO lentiviral vectors and lentiviral packaging were used as previously described 26 . Passage 3 MEFs and passage 2 glial cells were split onto 10 cm 0.2% gelatin-coated plates at 250,000 cells per plate 1 day before infection. Passage 1 tail tip fibroblasts were split onto 10 cm 0.2% gelatin-coated plates at 100,000 cells per plate 1 day before infection. Cells were infected in MEF medium supplemented with polybrene (8 mg ml 21 ; Sigma). One day after infection, MEF medium supplemented with doxycycline was added; this was considered to be day 0. Media were replaced every 2 days. On day 16, medium was replaced with mES cell medium without doxycycline. Owing to the complication of getting a large number of glial cells, we performed the reprogramming efficiency assays once per time point (days 6 and 9) but both were done with independently derived primary cells from different animals, independently derived virus and sorts.
The following compounds were also added to reprogramming medium on the days indicated in the text: BIO 1211 (Tocris, 4 nM), adenosine (Sigma, 20 mM or 2 mM as indicated), fibronectin (Sigma, 4 mg ml 21 ), AMP-CP (adenosine 59-(a,bmethylene)diphosphate) (Sigma, 20 mM). These were chosen as CD73 (59-nucleotidase, ecto) converts AMP to adenosine, CD49d (Itga4) is an integrin whose substrates are VCAM1 and fibronectin, a,b-methyleneadenosine 59-diphosphate (AMP-CP) is a CD73 inhibitor and BIO1211 is a CD49d inhibitor.
Hairpins for Nr0b1 and Etv5 were designed with the pSico oligomaker (Supplementary Table 3 ) and cloned into the lentiviral pSico-puro vector 28 (http://web. mit.edu/jacks-lab/protocols/pSico.html). We assessed knockdown efficiencies in partially reprogrammed cells as they express these genes and grow well in MEF medium supplemented with 15% serum alone. To assess knockdown efficiencies, 50,000 PRCs were plated onto a six-well gelatin-coated well 1 day before transduction. Cells were transduced with the hairpin of interest in MEF medium supplemented with 15% serum and polybrene (8 mg ml 21 ). The medium was exchanged the following day with MEF medium supplemented with 15% serum and puromycin (2 mg ml 21 ). Cells were cultured for a further 3 days before RNA extraction (for a total of 4 days after infection). RNA was prepared with an RNeasy purification kit as described below.
To assess the effects of knockdown of these genes on the day 9 CD73 high /CD49d high intermediate, 100,000 P4 Rosa-rtTA MEFs were plated on a 10 cm gelatin-coated plate. These were transduced the following day with the doxycycline-inducible FUW-tetO-Klf4, Oct3/4, Sox2 and c-Myc vectors and indicated hairpins as described above. Medium was supplemented with doxycycline 1 day after infection (day 0). We note that because Rosa-rtTA MEFs contain a PGK-puromycin cassette, they were not selected with puromycin. On day 9, CD73-Alexa 488 (1:50) and CD49d-Alexa 750 (1:50) were analysed by fluorescence-activated cell sorting (FACS staining described below). To assess reprogramming efficiencies for these genes, 30,000 P4 Rosa-rtTA MEFs were plated on a 6 cm gelatin-coated plate or 15,000 P4 Rosa-rtTA, Sox2-eGFP MEFs were plated on a six-well gelatin-coated well and transduced the following day in the same manner. At day 16, the culture medium was switched to mES cell medium without doxycycline. Twenty-four days after reprogramming induction, Nanog 1 colonies were assessed for Rosa-rtTA MEFs (immunofluorescence staining described below) or Sox2-eGFP 1 colonies for Rosa-rtTA, Sox2-eGFP MEFs. In total, three independent reprogramming efficient experiments were conducted across the two different MEF lines. To validate further the specificity of the effects, we performed a 'rescue' experiment to demonstrate that upon re-expression of the cDNA (under knockdown conditions) the effect is eliminated. To this end, the cDNAs for Nr0b1 and Etv5 were cloned into the FUW-tetO vector. Fifteen thousand P4 Rosa-rtTA MEFs on six-well gelatin-coated plates were then transduced with the doxycycline-inducible FUW-tetO-Klf4, Oct3/ 4, Sox2 and c-Myc vectors and indicated hairpins with the FUW-tetO-cDNA (Etv5 or Nr0b1) or an empty vector. Medium was supplemented with doxycycline 1 day after infection (day 0). On day 9, CD73-Alexa 488 (1:50) and CD49d-Alexa 750 (1:50) were analysed by FACS (FACS staining described below). As the rescue experiment was supplementary to and consistent with the main knockdown experiments, we conducted only one rescue experiment for one hairpin.
To verify that mouse ESCs could survive and proliferate after knockdown of Etv5 or Nr0b1, we infected 30,000 ESCs per well in gelatinized six-well plates in mESC medium and replaced the medium the following day with mESC medium supplemented with puromycin to select for successful transduction. These were then cultured for 3 days, dissociated with 0.25% trypsin and re-plated onto gelatinized six-well plates. These were then cultured for 3 days, fixed and stained for Oct4 (described below).
To reprogram Mbd3 fl/2 , Oct4-GFP secondary MEFs (the Oct4-GFP allele in these cells is not a targeted, but well-characterized, transgenic reporter 12 ), we first assayed reprogramming conditions with 2000 Mbd3 fl/2 secondary MEFs on 2 3 10 6 mitomycin-(Sigma) treated B6 feeders, 10 5 Mbd3 fl/2 secondary MEFs without feeders and 2 3 10 5 Mbd3 fl/2 secondary MEFs without feeders on 10 cm dishes coated with 0.2% gelatin. We found optimal reprogramming efficiencies with 2,000 Mbd3 fl/2 secondary MEFs and 2 3 10 6 feeders as previously reported 12 . All reprogramming assays were done in non-hypoxic conditions. To reprogram cells, cells were cultured in media 1 (recombinant human LIF (10 ng ml 21 , Peprotech), doxycycline (1 mg ml 21 ) and ascorbic acid (10 mg ml 21 , Sigma) in 15% cosmic calf serum (Thermo Scientific) in DMEM (Invitrogen) supplemented with non-essential amino acids (Invitrogen), penicillin-streptomycin (Invitrogen), sodium pyruvate (Invitrogen) and 2-mercaptoethanol (Invitrogen)) for 3 days and then media 2 (recombinant human LIF (10 ng ml 21 ), doxycycline (1 mg ml 21 ), PD0325901 (1 mM, Cell Signaling) and CHIR99021 (3 mM, Cayman) in 15% knockout replacement serum (Invitrogen) in DMEM (Invitrogen) supplemented with non-essential amino acids (Invitrogen), penicillin-streptomycin (Invitrogen), sodium pyruvate (Invitrogen) and 2-mercaptoethanol (Invitrogen)), until the completion of the experiment. Media were exchanged every 2 days. Mass cytometry analysis. On designated days the reprogramming cultures were treated with 13 TrypLE (Invitrogen) for 5 min at 37 uC, dissociated into single-cell suspension by trituration, and then washed twice with PBS. The cell samples were then incubated with metal-conjugated antibodies ( Supplementary Table 1 ) in PBS containing 5% FBS (Omega Scientific) for 30 min on ice, washed once with PBS containing 5% FBS, treated with 25 mM cisplatin for 1 min on ice for live-dead cell discrimination 29 , washed once with PBS containing 5% FBS and then fixed with 1.6% paraformaldehyde at 20 uC (room temperature) for 10 min. Formaldehydefixed cell samples were then permeabilized with methanol on ice for 15 min, washed once with PBS containing 0.5% BSA, and then incubated at room temperature for 15 min with an iridium-containing DNA intercalator (DVS Sciences/ Fluidigm) in PBS containing 1.6% paraformaldehyde. After intercalation/fixation, the cell samples were washed once with PBS containing 0.5% BSA and twice with water before measurement on a CyTOF mass cytometer (DVS Sciences/Fluidigm).
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Normalization for detector sensitivity was performed as previously described 30 , using polystyrene normalization beads containing lanthanum-139, praseodymium-141, terbium-159, thulium-169 and lutetium-175. Number of cells for each mass cytometry experiment are shown in Supplementary Table 2 . SPADE analysis. Density-dependent downsampling, hierarchical clustering, cluster upsampling and extraction of parameter medians was performed by the SPADE package (www.cytospade.org) as described in the main text and previously 23, 31 . All assayed surface markers were used in the clustering step unless otherwise indicated, and the parameters for downsampling percentile and target number of clusters were set to 5% and 500, respectively.
The refined poised signature shown in Fig. 3g was determined by calculating the similarity of each SPADE cluster to the hand-gated CD73 high CD49d high CD44 low CD326 low population. Similarity was calculated by the Manhattan distance metric using all measured surface markers, and is indicated by the coloured scale bar (low distance equals high similarity). Immunofluorescence. Plates were fixed in 4% PFA for 10 min, washed three times with PBS, blocked and permeabilized in PBS supplemented with 5% CCS and 0.1% Triton-X 100 (Sigma) (blocking solution) for 10 min. Ninety-six-well plates were then incubated with mouse anti-Nanog (1:500, BD) or mouse anti-Oct4 (1:200, Santa Cruz Biotechnology) in blocking solution for 30 min, washed three times with PBS, incubated with donkey anti-mouse Alexa-555 (1:1,000, Invitrogen) or antimouse Alexa-488 (1:1,000, Invitrogen) in blocking solution for 30 min, washed three times with PBS and stained with 49,6-diamidino-2-phenylindole (DAPI) for 3 min. Cells were then washed with PBS and visualized. FACS and efficiency assays. Cells were washed with PBS-EDTA, dissociated in 13 TrypLE for 5 min, washed with PBS and incubated on ice with a fluorophoreconjugated antibody and DAPI for 30 min in PBS-EDTA supplemented with 0.5% BSA. The sources and detailed descriptions of all antibodies used are listed in Supplementary Table 1 . For 96-well assays, single or 20 DAPI 2 cells per well were double sorted on the indicated day into gelatinized 96-well plates supplemented with 400,000 feeders per plate in MEF medium supplemented with doxycycline. For the primary sort, cells were sorted into PBS supplemented with 0.5% BSA; for the secondary sort, cells were sorted directly into 96-well plates. Efficiency assays were conducted 24 days after transgene induction and determined by the number of wells with Sox2-eGFP 1 colonies. For mass culture reprogramming, 10,000 SSEA1 high or SSEA1 low cells were double sorted 6 days after transgene induction onto 3 cm gelatinized plates supplemented with feeders, and Sox2-eGFP 1 colonies were assayed 24 days after transgene induction. We used the same SSEA1 clone and vendor as previously used for determining reprogramming efficiencies 8, 10 . Tail tip fibroblast and glial reprogramming efficiencies were determined by double sorting on the indicated days into 96-wells (as described above) and assaying for Nanog by immunofluorescence. Plating efficiencies were determined by infecting Sox2-eGFP MEFs with FUW-tetO-hygroB-T2A-eGFP, selecting for 5 days in hygromycin, and counting the number of wells with GFP 1 cells 24 h after sorting. For all assays where CD73 was used for sorting, CD73-Alexa 647 was used (gating shown in Extended Data Fig. 4 ). For CD73 3 CD49d analysis, CD73-Alexa 488 was used (Extended Data Fig. 7g ). RNA preparation and expression analysis. RNA of reprogramming populations for microarray analysis was prepared from Rosa-rtTA 6 day 6 and day 9 reprogramming cultures double sorted for CD73 or CD49d (as described above). RNA of con-trol populations for microarray analysis was prepared from Rosa-rtTA 6 MEFs (passage 4), partially reprogrammed cells (passage 10) and V6.5 mouse ESCs (passage 11). RNA was prepared with RNeasy Mini Kit (Qiagen) and DNA was removed by on-column RNase-Free DNase treatment (Qiagen) according to the manufacturer's instructions. Mouse Gene 2.0 ST Arrays (Affymetrix) were prepared by the Stanford Protein and Nucleic Acid Facility. Data were normalized and gene names were assigned by Partek Genomic Suite. For all analysis, non-coding transcripts were removed. Preprocessing (floor 5 100, ceiling 5 20,000, min fold change 5 2), k-means clustering (k 5 5, seed value 5 12345) and hierarchical clustering of k-means clusters (Pearson correlation, pairwise complete-linkage), and heat maps were generated by Gene Pattern (http://www.broadinstitute.org/cancer/ software/genepattern/). Microarray data can be accessed with accession number GSE62957 from the National Center for Biotechnology Information database. For Fig. 4a , genes were selected on the basis of pluripotency-associated genes characterized in previous studies 2, 7 or from differential expression of sorted populations and ESCs. Oct4 is not shown as the probe failed to detect expression in mESCs.
For quantitative PCR analysis, cDNA was generated with a SuperScript First-Strand Synthesis System (Invitrogen). Data were generated with a 7900HT Real-Time PCR System (Applied Biosystems). Six-microlitre reactions were prepared with SYBR Green Real-Time PCR Master Mix (Life Technologies) under the following conditions: 50 uC for 2 min, 95 uC for 10 min, and 40 cycles of 15 s at 95 uC and 1 min at 60 uC. All expression was normalized to GAPDH before comparing with control hairpin expression levels. Supplementary Table 3 gives primer sequences. Western blotting. Passage 3 Rosa-rtTA 6 MEFs or secondary Mbd3 fl/2 , Rosa26-CreER MEFs were grown in 10-cm tissue culture plates. Secondary Mbd3 fl/2 MEFs were treated with 1 mM 4OH-tamoxifen for 24 h, then samples were cultured for a further 48 h and dissociated with 0.25% trypsin. The cell pellet was then lysed with cell lysis buffer (200 mM NaCL, 50 mM Tris pH8.0, 1% Trion X-100, 5% glycerol). Twenty micrograms of soluble protein was run on a 4-12% gradient Bis-Tris gel (Life Technologies) and blotted onto PVDF membrane. After blocking, membrane was incubated with primary antibody against Mbd3 (1:1,000, Bethyl Laboratories, A302-528A) for 1 h at room temperature, washed three times with PBS with 0.1% Tween-20 and incubated with secondary antibody anti-rabbit HRP (1:5,000, Jackson Immuno, A5441) for 1 h at room temperature.
Extended Data Figure 5 | Day 6 continuation analysis on day 16. a, Schematic of continuation analysis. Reprogramming populations were sorted for poised (CD73 high or CD49 high ) and non-poised (CD73 low ) populations on day 6, cultured for 10 days on a 3 cm plate and analysed by mass cytometry on day 16. b, Morphology of CD49d high , CD73 high or CD73 low cells sorted on day 6 and inspected on day 10. Poised CD49d high or CD73 high cells form compact colonies within several days of sorting while non-poised CD73 low cells fail to do so. c, SPADE analysis (day 16) of cells sorted at day 6 for CD73 high /CD49d high CD73 high , CD49 high and CD73 low expression (continued from Fig. 3h ). Boxes highlight a SSEA1 high CD326 high branch that is unique to the poised populations. Colours bars (bottom) ArcSinh-transformed counts for each marker.
G2015 Macmillan Publishers Limited. All rights reserved Extended Data Figure 6 | Continuation analysis replicates confirm a SSEA1 high CD326 high branch that is unique to poised populations. Continuation analysis replicates for reprogramming-prone (CD73 high / CD49d high , CD73 high , CD49d high ) and non-prone (CD73 low ) populations.
Boxes highlight a SSEA1 high CD326 high branch that is unique to the poised populations. Colours bars (bottom) represent absolute percentages (left panel) and ArcSinh-transformed counts for each marker.
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G2015 Macmillan Publishers Limited. All rights reserved Extended Data Figure 7 | Molecular characterization of reprogrammingprone intermediates. a, Genes differentially expressed between reprogramming-prone (day 6 or day 9 CD73 high or CD49d high ) and non-prone (CD73 low ) populations. Genes with more than twofold differential expression between reprogramming-prone and non-prone were selected and k-means clustered (k 5 5) with control and total reprogramming population expression values. b, Heat map of pluripotency-associated genes shown in Fig. 4a (log 2 ) . c, d, Quantitative PCR verification of Etv5 (c) and Nr0b1 (d) expression levels (n 5 3 technical replicates). e, f, Etv5 (e) and Nr0b1 (f) knockdown qPCRs (n 5 3 technical replicates). g, Representative FACS plots for day 9 CD73 high /CD49d high quantification shown in Fig. 4b . h, Demonstration of ESC self-renewal after infection with Etv5 and Nr0b1 hairpins All infected ESCs continue to express Oct4 after passaging except ESCs infected with shEtv5-8 (n 5 1). 
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